APC 366 is a selective mast cell tryptase inhibitor used in research to study the treatment of allergic asthma by addressing antigen-induced early and late asthmatic responses alongside bronchial hyperresponsiveness.… Read more
APC 366 is a selective mast cell tryptase inhibitor used in research to study the treatment of allergic asthma by addressing antigen-induced early and late asthmatic responses alongside bronchial hyperresponsiveness. To support rigorous pharmaceutical analysis, this category provides high-quality reference standards of the API, alongside its pharmacopeial and non-pharmacopeial impurities and stable isotope labelled compounds. These specialized materials are essential for pharmaceutical laboratories during impurity profiling, method validation, and routine quality control processes. By utilizing these precise reference materials, researchers and analysts can accurately identify and quantify degradants and by-products within drug substances and drug products, ensuring compliance with regulatory standards for safety and efficacy throughout the development lifecycle.